Without such nuance, users risk being stereotyped as vain or irresponsible, while the deeper structural pressures that normalize pharmaceutical thinness remain invisible
Semaglutide, a medication commonly used for treating type 2 diabetes and for weight management, has been linked to gastrointestinal (GI) side effects in some patients
It is contraindicated for pregnant or nursing women
Notably, around 16% of patients may need to stop using tirzepatide or adjust their dosage due to these reactions, which can include stomach discomfort, nausea, and a metallic taste in the mouth
Emerging, largely preclinical research into the gut-brain axis suggests it may influence serotonin activity and neuroinflammation, since a large share of the body's serotonin is produced in the gut